Genetron Health Announces Co-Development Agreement with Astr

Genetron Health Announces Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China

30.11.2021 - Collaboration highlights the value of MRD solid tumor data generated by Genetron’s Mutation Capsule platform, and further accelerates product developmentBEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) - Genetron Holdings Limited (“Genetron Health” or the ... Seite 1

Related Keywords

China , Jing He , Sichuan , Sizhen Wang , Astrazeneca , Genetron Health , Senior Vice President , Mutation Capsule ,

© 2025 Vimarsana